JOHNSON & JOHNSON (JNJ) Business News July 31, 2026, 13:14 UTC Clinical trial NCT05265273: primary completion date: 2026-06-26 → 2027-06-30. Full text
Register to leave comments News bot July 31, 2026, 1:18 p.m. 📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical